相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
Epigenetic biomarkers in colorectal cancer diagnostics
James B. Rawson et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2012)
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Toshinori Hinoue et al.
GENOME RESEARCH (2012)
Prediction in the face of uncertainty: A Monte Carlo-based approach for systems biology of cancer treatment
Christoph Wierling et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2012)
Recurrent R-spondin fusions in colon cancer
Somasekar Seshagiri et al.
NATURE (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
TFAP2E-DKK4 and Chemoresistance in Colorectal Cancer
Matthias P. A. Ebert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Recent approaches to identifying biomarkers for high-risk stage II colon cancer
Takashi Akiyoshi et al.
SURGERY TODAY (2012)
Genome-wide DNA Methylation Events in TMPRSS2-ERG Fusion-Negative Prostate Cancers Implicate an EZH2-Dependent Mechanism with miR-26a Hypermethylation
Stefan T. Boerno et al.
CANCER DISCOVERY (2012)
Base-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid Leukemia
Altuna Akalin et al.
PLOS GENETICS (2012)
Molecular Genetics of Colorectal Cancer
Eric R. Fearon
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy
Byung-Hoon Min et al.
BMC CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
The power of NGS technologies to delineate the genome organization in cancer: from mutations to structural variations and epigenetic alterations
Michal R. Schweiger et al.
CANCER AND METASTASIS REVIEWS (2011)
Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer
Kazuyuki Kawakami et al.
CANCER SCIENCE (2011)
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
Francesco Crea et al.
DRUG RESISTANCE UPDATES (2011)
5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer
Rodrigo Jover et al.
GASTROENTEROLOGY (2011)
Colorectal Cancer Epigenetics: Complex Simplicity
Manon van Engeland et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue
Richard D. Kennedy et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion
Adam J. Bass et al.
NATURE GENETICS (2011)
Resistance, epigenetics and the cancer ecosystem
Stephen B. Baylin
NATURE MEDICINE (2011)
Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases
Vlastimil Kulda et al.
CANCER GENETICS AND CYTOGENETICS (2010)
MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening
Yoshikatsu Koga et al.
CANCER PREVENTION RESEARCH (2010)
Defective Mismatch Repair, Microsatellite Mutation Bias, and Variability in Clinical Cancer Phenotypes
Sandeep N. Shah et al.
CANCER RESEARCH (2010)
A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Two Schedules of Vorinostat in Combination with 5-Fluorouracil and Leucovorin in Patients with Refractory Solid Tumors
Marwan G. Fakih et al.
CLINICAL CANCER RESEARCH (2010)
Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data
Cecilia Guastadisegni et al.
EUROPEAN JOURNAL OF CANCER (2010)
Microsatellite Instability in Colorectal Cancer
C. Richard Boland et al.
GASTROENTEROLOGY (2010)
Use of Cancer-Specific Genomic Rearrangements to Quantify Disease Burden in Plasma from Patients with Solid Tumors
David J. McBride et al.
GENES CHROMOSOMES & CANCER (2010)
DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome
George Poulogiannis et al.
HISTOPATHOLOGY (2010)
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
Zhaohui Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Microsatellite instability in colorectal cancer-the stable evidence
Eduardo Vilar et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
DNMT3A Mutations in Acute Myeloid Leukemia.
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Somatic Mutation Profiles of MSI and MSS Colorectal Cancer Identified by Whole Exome Next Generation Sequencing and Bioinformatics Analysis
Bernd Timmermann et al.
PLOS ONE (2010)
Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression
Anke H. Sillars-Hardebol et al.
TUMOR BIOLOGY (2010)
Next-generation sequencing technologies for DNA methylation analyses in cancer genomics
Stefan T. Boerno et al.
EPIGENOMICS (2010)
From discovery to the clinic: the novel DNA methylation biomarker mSEPT9 for the detection of colorectal cancer in blood
Shannon R. Payne
EPIGENOMICS (2010)
Applications of New Sequencing Technologies for Transcriptome Analysis
Olena Morozova et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS (2009)
Epigenetic mechanisms in cancer
Hirendra Nath Banerjee et al.
BIOMARKERS IN MEDICINE (2009)
The miR-18a*microRNA functions as a potential tumor suppressor by targeting on K-Ras
Wing Pui Tsang et al.
CARCINOGENESIS (2009)
Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors
Ruth Plummer et al.
CLINICAL CANCER RESEARCH (2009)
Clinicopathological significance of microRNA-31,-143 and-145 expression in colorectal cancer
Chao-Jie Wang et al.
DISEASE MARKERS (2009)
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
E. K. O. Ng et al.
GUT (2009)
Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells
William Fazzone et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence
Rachel R. Huxley et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
miR-21: a small multi-faceted RNA
Anna M. Krichevsky et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Mechanism of Growth Inhibition by MicroRNA 145: The Role of the IGF-I Receptor Signaling Pathway
Gaspare La Rocca et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Cytoplasmic functions of the tumour suppressor p53
Douglas R. Green et al.
NATURE (2009)
Role of miR-143 targeting KRAS in colorectal tumorigenesis
X. Chen et al.
ONCOGENE (2009)
Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer
Michal Sheffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Translation of the Philadelphia chromosome into therapy for CML
Brian J. Druker
BLOOD (2008)
A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition
Cameron P. Bracken et al.
CANCER RESEARCH (2008)
Diagnostic and prognostic microRNAs in stage II colon cancer
Troels Schepeler et al.
CANCER RESEARCH (2008)
Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer
Remco Nagel et al.
CANCER RESEARCH (2008)
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Dmitri Lodygin et al.
CELL CYCLE (2008)
Unraveling the Biologic and Clinical Complexities of HER2
John W. Park et al.
CLINICAL BREAST CANCER (2008)
DNA methylation biomarkers for blood-based colorectal cancer screening
Catherine Lofton-Day et al.
CLINICAL CHEMISTRY (2008)
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
Ulrike Burk et al.
EMBO REPORTS (2008)
The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers
Chunguang Guo et al.
GENES CHROMOSOMES & CANCER (2008)
Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer
Johan Vansteenkiste et al.
INVESTIGATIONAL NEW DRUGS (2008)
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma
Aaron J. Schetter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
Manav Korpal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators
Galina Gabriely et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
The genetics of the p53 pathway, apoptosis and cancer therapy
Alexei Vazquez et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
Robert Gruetzmann et al.
PLOS ONE (2008)
miR-34a repression of SIRT1 regulates apoptosis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome
Marc Sultan et al.
SCIENCE (2008)
APC shuttling to the membrane, nucleus and beyond
Mariana Brocardo et al.
TRENDS IN CELL BIOLOGY (2008)
The methylome: approaches for global DNA methylation profiling
Stephan Beck et al.
TRENDS IN GENETICS (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
I. A. Asangani et al.
ONCOGENE (2008)
The genomic landscapes of human breast and colorectal cancers
Laura D. Wood et al.
SCIENCE (2007)
Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells
Bin Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The genetics of hereditary colon cancer
Anil K. Rustgi
GENES & DEVELOPMENT (2007)
Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer
Megan P. Hitchins et al.
CANCER RESEARCH (2007)
Adenomatous polyposis coli (APC):: a multi-functional tumor suppressor gene
Koji Aoki et al.
JOURNAL OF CELL SCIENCE (2007)
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
Hiroshi Tazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Insulin pathway related genes and risk of colorectal cancer:: INSR promoter polymorphism shows a protective effect
Sonali Pechlivanis et al.
ENDOCRINE-RELATED CANCER (2007)
p53-mediated activation of miRNA34 candidate tumor-suppressor genes
Guido T. Bommer et al.
CURRENT BIOLOGY (2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
miR-200b mediates post-transcriptional repression of ZFHX1B
Nanna Ronbjerg Christoffersen et al.
RNA (2007)
Let-7 expression defines two differentiation stages of cancer
Scott Shell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Tsung-Cheng Chang et al.
MOLECULAR CELL (2007)
Phenotypic plasticity and the epigenetics of human disease
Andrew P. Feinberg
NATURE (2007)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman et al.
NATURE (2007)
The many ways of Wnt in cancer
Paul Polakis
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Highly methylated genes in colorectal neoplasia: Implications for screening
Hongzhi Zou et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin
Gregory J. Hurteau et al.
CANCER RESEARCH (2007)
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer
O. Slaby et al.
ONCOLOGY (2007)
Colorectal cancer and genetic alterations in the Wnt pathway
S. Segditsas et al.
ONCOGENE (2006)
Polycomb silencers control cell fate, development and cancer
Anke Sparmann et al.
NATURE REVIEWS CANCER (2006)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
MicroRNA-cancer connection: The beginning of a new tale
George Adrian Calin et al.
CANCER RESEARCH (2006)
Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band
J Frigola et al.
NATURE GENETICS (2006)
let-7 microRNA functions as a potential growth suppressor in human colon cancer cells
Yukihiro Akao et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Epigenetics as a mechanism driving polygenic clinical drug resistance
RM Glasspool et al.
BRITISH JOURNAL OF CANCER (2006)
Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage
K Suzuki et al.
CANCER CELL (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Familial adenomatous polyposis
P Galiatsatos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster
Michael Dews et al.
NATURE GENETICS (2006)
Kaiso-deficient mice show resistance to intestinal cancer
A Prokhortchouk et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Refining molecular analysis in the pathways of colorectal carcinogenesis
A Rowan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
A postulated role for microRNA in cellular differentiation
I Bentwich
FASEB JOURNAL (2005)
Statins and the risk of colorectal cancer
JN Poynter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Molecular staging for survival prediction of colorectal cancer patients
S Eschrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Colorectal cancer screening in average risk individuals
CS Huang et al.
CANCER CAUSES & CONTROL (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Methylation changes in faecal DNA:: a marker for colorectal cancer screening?
HM Müller et al.
LANCET (2004)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters
F Bertucci et al.
ONCOGENE (2004)
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population
TF Imperiale et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Opinion - CpG island methylator phenotype in cancer
JP Issa
NATURE REVIEWS CANCER (2004)
Epigenetic changes in colorectal cancer
Y Kondo et al.
CANCER AND METASTASIS REVIEWS (2004)
Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma
A Ota et al.
CANCER RESEARCH (2004)
Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines
CN Arnold et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
DNA integrity as a potential marker for stool-based detection of colorectal cancer
KA Boynton et al.
CLINICAL CHEMISTRY (2003)
Deficiency of Mbd2 suppresses intestinal tumorigenesis
OJ Sansom et al.
NATURE GENETICS (2003)
Mutational analysis of the tyrosine kinome in colorectal cancers
A Bardelli et al.
SCIENCE (2003)
Genomic medicine - Hereditary colorectal cancer
HT Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
DNA methylation in cancer: too much, but also too little
M Ehrlich
ONCOGENE (2002)
Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas
YM Lin et al.
ONCOGENE (2002)
Biology of the adenomatous polyposis coli tumor suppressor
KH Goss et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
